Hansol Lee1, Sun-Yong Baek2, Eun-Joo Kim3, Gi Yeong Huh4, Jae-Hyeok Lee5, and HyungJoon Cho1
1Department of Biomedical Engineering, Ulsan National Institute of Science and Technology, Ulsan, Korea, Republic of, 2Department of Anatomy, Pusan National University School of Medicine, Yangsan, Korea, Republic of, 3Department of Neurology, Pusan National University Hospital, Busan, Korea, Republic of, 4Department of Forensic Medicine, Pusan National University School of Medicine, Yangsan, Korea, Republic of, 5Department of Neurology, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea, Republic of
Synopsis
The purpose of this study was to determine the morphology change in the
substantia nigra of progressive supranuclear palsy using MRI with
histopathological validation. MR experiments for progressive supranuclear palsy
brains were operated using 3T in vivo and 7T postmortem imaging systems.
Perls’ Prussian blue staining, Luxol fast blue staining, and LA-ICP-MS for 2D
iron mapping confirmed the large amount of iron deposits along the myelinated
fibers within substantia nigra of PSP brain. The iron deposits along the myelinated
fibers could be the potential source causing the blurred boundary between red
nucleus and substantia nigra in in vivo MRI.
Purpose
Progressive supranuclear palsy (PSP) is a rare neurodegenerative disorder with
predominant features of parkinsonism from abnormal tau protein aggregation and marked
loss of dopaminergic neurons1, 2. The atrophy of midbrain including
substantia nigra (SN) is one of the typical pathological characteristics of PSP
identified in MRI studies2. In the SN, neuromelanin pigments and
deposited iron molecules are dominant contributors in MRI contrast3.
T1-weighted image with magnetization transfer (MT) effects for
neuromelanin-sensitive MRI and transverse relaxometry-based imaging for
iron-sensitive MRI have been investigated to non-invasively monitor the
progression of Parkinsonism3. Additionally, the dopaminergic
projection appears mainly from SN pars compacta and GABAergic neuron originates
from SN pars reticulata. This study aimed to investigate the morphological
alterations of microarchitecture within the SN with disease progression of PSP
through direct comparison among MRI, histology, and mass spectrometer.Methods
The postmortem midbrain samples were obtained from one normal subject and
one patient with a diagnosis of PSP. High-resolution MRI of postmortem brains
was conducted at 7T preclinical scanner (Bruker, Germany) for T1-weighted
image with additional MT contrast preparation pulses and T2*-weighted
image. After MR scans, the cryoprotected brain tissues were sectioned to 50 m thickness for Perls’
Prussian blue staining and Luxol fast blue staining. 2D iron mapping (56Fe/13C)
was performed by Laser ablation inductively coupled plasma mass spectrometry
(LA-ICP-MS). The postmortem MRI, stained slides, and 56Fe/13C
iron map were co-registered for direct comparison. The normal controls and PSP
patients underwent 3T in vivo MRI. T2*-weighted
image with the oblique-axial plan was acquired parallel to the AC-PC line with the
following parameters: TR = 406 ms, TE = 13.47 ms, and FA = 20 °.Results
For both normal and PSP brains, the
hypointense area in the T1-weighted image with MT effects (Figure
1I-A and 1II-A) showed the myelinated fiber within anteriomedial SN identified
from Luxol fast blue staining (Figure 1I-C and 1II-C). For the normal brain, the
structure of nigrosome 1 was detected as a hyperintense area in the T2*-weighted
image (orange asterisk in Figure 1I-B). This area corresponded to the
hyperintensity in the T1-weighted image with lower iron content in co-registered
Perls’ Prussian blue staining (Figure 1I-D). The positively stained region of
Perl’s Prussian blue staining highly co-localized with the elevated signals in
56Fe/13C intensity from LA-ICP-MS imaging (Figure 1I-E).
For the PSP brain, red circles in the T1-weighted
image with MT effects (Figure 1II-A) and Luxol fast blue staining (Figure
1II-C) showed the neuronal projection of the 3rd cranial nerve and
myelinated fiber within anteriomedial SN. In the high-resolution T2*-weighted
image (Figure 1II-B) within SN of PSP brain, the hypointensity showed the
linear patterns across the SN. However, their linearities were identified in
Perls’ Prussian blue staining (Figure 1II-D) and were not shown in Luxol fast
blue staining. The iron deposits along myelinated fibers in the red circles were
identified in 56Fe/13C intensity of LA-ICP-MS imaging
(Figure 1II-E), which was not detected in Perls’ Prussian blue staining.
In the 3T in vivo T2*-weighted
image, the boundary between SN and red nucleus was clearly visible in normal
controls (Figure 2I). On the other hand, it disappeared in the PSP brain with
the connection of hypointense signals (Figure 2II).Discussions
In this study, the evidence of iron deposition along myelinated fiber
within anteriomedial SN was identified in PSP
through the validation utilizing diverse approaches. Defining anatomy and
delineating the subregions of the SN are still controversial even in the
high-field MRI. The various sources within the SN of Parkinsonism complicate
the interpretation of in vivo MRI. The iron deposits along myelinated
fibers in the PSP brain reflect the iron deposits causing loss of myelinated
nerve fibers with neurodegenerative diseases. However, the linear hypointense
patterns in the T2*-weighted image of the postmortem PSP
brain were not precisely determined in direct histopathological validation. The
perivascular iron deposition could be one of the potential candidates bringing T2*
shortening effect within SN. Further studies with more samples of PSP brains with
additional histopathological experiments are needed for the improved
interpretation of in vivo brain MRI of Parkinsonism.Acknowledgements
This work
was supported by the Korea Health Industry Development Institute by the 2019
Research Fund (HI18C0713).References
1. Gerstenecker, A., Duff, K., Mast, B., Litvan, I., & ENGENE-PSP Study
Group. (2013). Behavioral abnormalities in progressive supranuclear
palsy. Psychiatry research, 210(3), 1205-1210.
2. Liscic, R. M., Srulijes, K., Gröger, A., Maetzler, W., & Berg, D.
(2013). Differentiation of progressive supranuclear palsy: clinical, imaging
and laboratory tools. Acta Neurologica Scandinavica, 127(5),
362-370. Sasaki, M., Shibata, E., Kudo, K., & Tohyama, K. (2008).
Neuromelanin-sensitive MRI. Clinical Neuroradiology, 18(3),
147-153.
3. Lehéricy, S., Sharman, M. A., Santos, C. L. D., Paquin, R., & Gallea,
C. (2012). Magnetic resonance imaging of the substantia nigra in Parkinson's
disease. Movement disorders, 27(7),
822-830.